FOXO4-DRI (10 mg Vial) Dosage Protocol

Quickstart Highlights

FOXO4-DRI dosage protocols focus on this innovative senolytic peptide (also known as Proxofim) designed to selectively target and eliminate senescent “zombie” cells. As a D-retro-inverso analog of the FOXO4 protein segment, FOXO4-DRI works by disrupting the FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis and clear dysfunctional cells^[1]^[2]. Preclinical research has demonstrated benefits including improved physical fitness, restored organ function, enhanced hormonal balance, and reduced tissue fibrosis in aged animal models^[3]^[4]. This educational protocol presents an intermittent subcutaneous approach using a practical dilution for accurate insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → 3.33 mg/mL concentration.

Typical dose range: 300–500 mcg once daily during dosing weeks.

Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (36–46 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and intermittent pulse dosing

Standard / Intermittent Pulse Approach (3 mL = 3.33 mg/mL)

Week/Phase	Daily Dose (mcg)	Units (per injection) (mL)
Week 1 (Days 1–7)	300 mcg	9 units (0.09 mL)
Week 2 (Days 8–14)	Off	No injection
Week 3 (Days 15–21)	400 mcg	12 units (0.12 mL)
Week 4 (Days 22–28)	Off	No injection

Frequency: Inject once daily subcutaneously during dosing weeks. Senolytics like FOXO4-DRI are most effective with intermittent “hit-and-run” dosing rather than continuous administration^[2]^[5]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming or harsh agitation.

Gently swirl/roll until dissolved (do not shake).

Label with date and refrigerate at 2–8 °C (36–46 °F), protected from light.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on a 2–4 week intermittent protocol (1 week on, 1 week off cycles).

Peptide Vials (FOXO4-DRI, 10 mg each):

1 cycle (7 doses at 400 mcg) ≈ 2.8 mg → 1 vial
2 cycles (14 doses at 400 mcg) ≈ 5.6 mg → 1 vial
3 cycles (21 doses at 500 mcg) ≈ 10.5 mg → 2 vials

Insulin Syringes (U-100):

Per dosing week: 7 syringes (1/day)
1 cycle (2 weeks): 7 syringes
2 cycles (4 weeks): 14 syringes
3 cycles (6 weeks): 21 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

1–2 cycles (1 vial): 3 mL → 1 × 10 mL bottle
3 cycles (2 vials): 6 mL → 1 × 10 mL bottle

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per dosing week: 14 swabs (2/day)
1 cycle: 14 swabs
2 cycles: 28 swabs
3 cycles: 42 swabs → recommend 1 × 100-count box

View Supplier

Protocol Overview

Concise summary of the intermittent senolytic regimen.

Goal: Selectively eliminate senescent cells to support tissue rejuvenation and restore healthy cellular function^[1]^[3].

Schedule: 1 week on, 1 week off cycles; 1–3 cycles total (2–6 weeks).

Dose Range: 300–500 mcg daily during dosing weeks.

Reconstitution: 3.0 mL per 10 mg vial (3.33 mg/mL) for accurate unit measurements.

Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.

Research Disclaimer